May 15, 2012 — A simple clinical assessment performed in the doctor’s office can identify patients who are at high risk for stroke and other major complications following a procedure to clear blockages from the neck arteries that supply blood to the brain, according to a study presented at the SCAI 2012 Scientific Sessions.

May 15, 2012 — In a keynote Founders’ Lecture at the Society for Cardiovascular Angiography and Interventions (SCAI) 2012 Scientific Session on May 10, Ted Feldman, M.D., FSCAI, highlighted how percutaneous valve therapies may soon be the accepted treatment for a wide range of patients.


May 15, 2012 – St. Jude Medical Inc., a global medical device company, announced CE mark approval and launch of its EnligHTN renal denervation system during EuroPCR. Renal denervation is a specialized ablation procedure that has been clinically proven to reduce blood pressure in patients with hypertension, or high blood pressure, that is resistant to medical therapy. 

Hardware and software advances are enabling echocardiography to greatly expand its capability with increased quantification accuracy, ease-of-use, increased workflow efficiencies and wider use outside of echo labs. Today, cardiovascular ultrasound systems are being integrated into point-of-care for triage, and in operating rooms and cath labs for procedural guidance to cut the use of contrast and ionizing radiation. 

May 15, 2012 — Reaching out to patients with a few simple phone calls significantly improves the likelihood they’ll continue to take critically important medication that keeps blood clots from clogging a new stent, according to a study presented today at the SCAI 2012 Scientific Sessions.

As an editor for DAIC and Imaging Technology News, I am a third-party observer in the cardiac and radiology markets. I also am a  patient who recently received medical imaging. With both these sets of experience, I am of the opinion that physicians often miss an opportunity to connect with their patients in a critical way, one which could increase patient involvement and compliance for treatments and follow-up exams.  


As an editor for DAIC and Imaging Technology News, I am a third-party observer in the cardiac and radiology markets. I also am a  patient who recently received medical imaging. With both these sets of experience, I am of the opinion that physicians often miss an opportunity to connect with their patients in a critical way, one which could increase patient involvement and compliance for treatments and follow-up exams.  
Contrast media injectors. angiography contrast injectors

Two next-generation automated contrast injector systems were recently introduced in the United States. 

 

Medical devices employed for injecting radio-opaque contrast media into the body to enhance the visibility of tissues for a medical imaging procedure are known as contrast injectors. Over the years, with ever-increasing technological sophistication, these contrast injectors have evolved from manual injectors having manifolds with stop-cocks to automated versions, providing added accuracy and advantages. These automated versions are known as autoinjectors. Autoinjectors are capable of controlling the amount of contrast media injected, utilization rate, and are also able to increase dosage to keep pace with fast medical imaging scanners as well as alert the physician of potential hazards, such as air embolisms or extravasations.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now